Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 199-209

  Zhai, Yongzhen ^a   Zhou, Yan ^a   Li, Ximei ^a   Feng, Guohe ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chitosan; Cytotoxic T lymphocytes; Dendritic cells; Granulocyte macrophage colony stimulating factor; Japanese encephalitis virus; Nanoparticles

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHITOSAN; DNA VACCINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; JAPANESE ENCEPHALITIS VACCINE; JAPANESE ENCEPHALITIS VIRUS PREMEMBRANE ENVELOPE PROTEIN VACCINE; NANOPARTICLE; OVALBUMIN; UNCLASSIFIED DRUG; GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 2; IMMUNOLOGICAL ADJUVANT; PRM PROTEIN, FLAVIVIRUS; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; CELL COUNT; CELL FUNCTION; CELL INFILTRATION; CELL SUSPENSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY ASSAY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PH; PROTEIN EXPRESSION; SPLEEN CELL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CHEMISTRY; DRUG EFFECTS; ENCEPHALITIS, JAPANESE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; JAPANESE ENCEPHALITIS VIRUS; MACROPHAGE; NEUTROPHIL; PLASMID; SKELETAL MUSCLE; SPLEEN; VIROLOGY;

JAPANESE ENCEPHALITIS VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD11C; CELL MOVEMENT; CHITOSAN; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; INJECTIONS, INTRAMUSCULAR; MACROPHAGES; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; NANOPARTICLES; NEUTROPHILS; PLASMIDS; SPLEEN; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84926628007     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3419     Document Type: Article

References (42)

1. Yamamoto A, Nakayama M, Kurosawa Y, et al: Development of a particle agglutination assay system for detecting Japanese encephalitis virus-specific human IgM, using hydroxyapatite-coated nylon beads. J Virol Methods 104: 195-201, 2002.
2. Solomon T and Vaughn DW: Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 267: 171-194, 2002.
3. Hoke CH, Nisalak A, Sangawhipa N, et al: Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608-614, 1988.
4. Ueba N, Kimura T, Nakajima S, Kurimura T and Kitaura T: Field experiments on live attenuated Japanese encephalitis virus vaccine for swine. Biken J 21: 95-103, 1978.
5. Xin YY, Ming ZG, Peng GY, Jian A, and Min LH,: Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39: 214-217, 1988.
6. Plesner AM and Ronne T: Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine 15: 1239-1243, 1997.
7. Andersen MM, and Rønne T,: Side-effects with Japanese encephalitis vaccine. Lancet 337: 1044, 1991.
8. Ruff TA, Eisen D, Fuller A and Kass R: Adverse reactions to Japanese encephalitis vaccine. Lancet 338: 881-882, 1991.
9. Sakaguchi M, Yoshida M, Kuroda W, Harayama O, Matsunaga Y and Inouye S: Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine 15: 121-122, 1997.
10. Liu MA: DNA vaccines: a review. J InternMed 253: 402-410, 2003.
11. Putnak R, Porter K and Schmaljohn C: DNA vaccines for flaviviruses. Adv Virus Res 61: 445-468, 2003.
12. Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Takada K and Mason PW: The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 73: 5527-5534, 1999.
13. Konishi E, Ajiro N, Nukuzuma C, Mason PW and Kurane I: Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine 21: 3675-3683, 2003.
14. Wu CJ, Li TL, Huang HW, Tao MH and Chan YL: Development of an effective Japanese encephalitis virus-specific DNA vaccine. Microbes Infect 8: 2578-2586, 2006.
15. Kaur R, Sachdeva G and Vrati S: Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J Infect Dis 185: 1-12, 2002.
16. Bharati K, Appaiahgari MB and Vrati S: Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice. Microbiol Immunol 49: 349-353, 2005.
17. Kutzler MA and Weiner DB: Developing DNA vaccines that call to dendritic cells. J Clin Invest 114: 1241-1244, 2004.
18. Daro E, Pulendran B, Brasel K, et al: Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but not CD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J Immunol 165: 49-58, 2000.
19. Daro E, Butz E, Smith J, Teepe M, Maliszewski CR and McKenna HJ: Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF. Cytokine 17: 119-130, 2002.
20. Hanada K, Tsunoda R and Hamada H: GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity. J Leukoc Biol 60: 181-190, 1996.
21. Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M and Dranoff G: Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res 60: 3239-3246, 2000.
22. Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539-3543, 1993.
23. Chiodoni C, Paglia P, Stoppacciaro A, Rodolfo M, Parenza M and Colombo MP: Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J Exp Med 190: 125-133, 1999.
24. Zaharoff DA, Rogers CJ, Hance KW, Schlom J and Greiner JW: Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine 25: 8673-8686, 2007.
25. Pouton CW and Seymour LW: Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46: 187-203, 2001.
26. Crystal RG: The gene as the drug. Nat Med 1: 15-17, 1995.
27. Garnett MC: Gene-delivery systems using cationic polymers. Crit Rev Ther Drug Carrier Syst 16: 147-207, 1999.
28. Read RC, Naylor SC, Potter CW, et al: Effective nasal influenza vaccine delivery using chitosan. Vaccine 23: 4367-4374, 2005.
29. Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL and Alonso MJ: Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 57: 123-131, 2004.
30. Van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J and Junginger HE: Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 21: 1400-1408, 2003.
31. Mao HQ, Roy K, Troung-Le VL, et al: Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 70: 399-421, 2001.
32. Haddad D, Ramprakash J, Sedegah M, et al: Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J Immunol 165: 3772-3781, 2000.
33. Zhai YZ, Zhou Y, Ma L and Feng GH: The dominant roles of ICAM-1-encoding gene in DNA vaccination against Japanese encephalitis virus are the activation of dendritic cells and enhancement of cellular immunity. Cell Immunol 281: 1-10, 2013.
34. Zhai YZ, Li XM, Zhou Y and Feng GH: Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: Enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF. Intervirology 52: 152-163, 2009.
35. Gordon S, Teichmann E, Young K, Finnie K, Rades T and Hook S: In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery. Eur J Pharm Sci 41: 360-368, 2010.
36. +T lymphocyte responses. Eur J Immunol 34: 1011-1020, 2004.
37. Oka Y, Akbar SM, Horiike N, Joko K and Onji M: Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 103: 90-97, 2001.
38. Cella M, Sallusto F and Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10-16, 1997.
39. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
40. Mellman I, Turley SJ and Steinman RM: Antigen processing for amateurs and professionals. Trends Cell Biol 8: 231-237, 1998.
41. Steinman RM: Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 68: 160-166, 2001.
42. Seferian PG, and Martinez ML,: Imune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 19: 661-668, 2000.